Drug compound leads to death of ovarian cancer cells resistant to ch... ( In a discovery that may be useful fo...)

Drug compound leads to death of ovarian cancer cells resistant to chemotherapy

Date:4/17/2008

In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.

Gil Mor, M.D., associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, and associate research scientist Ayesha Alvero, M.D. presented the data April 15 during an oral presentation at the annual meeting of the American Association for Cancer Research.

In cancer cells, mTOR signals enhance tumor growth and may be associated with resistance to conventional therapies. Inhibition of mTOR could shut down many of these survival pathways, including proteins that protect the mitochondria of cancer cells.

NV-128, developed by Novogen Limited, holds promise as a more targeted therapy for ovarian cancer because it works differently from traditional therapies that are dependent on enzymes known as caspases to trigger cell death. Therapies using caspases to kill cancer cells can be ineffective in chemo-resistant cancer cells due to mutations that short-circuit signals that trigger cancer cell death.

We consider that the capacity of NV-128 to trigger caspase-independent cell death, in otherwise chemoresistant ovarian cancer cells, opens new possibilities for the use of NV-128 as a potential addition to conventional chemotherapy targeting ovarian cancer cells, said Mor.

In the context of developing therapies for late stage ovarian cancer, Mor said, the finding may be a key step to the development of alternative targeted therapy for patients with cancer recurrence.

'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

0

GOOD

Post Your Comments:

Related Image:

Drug compound leads to death of ovarian cancer cells resistant to chemotherapy

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... to impossible, but a new study adds to a ... CT scans may help spot the beginnings of disease ... the greatest risk for lung cancer, 6 percent were ... and follow-up biopsies to confirm the diagnosis. CT scans ...

(Date:5/21/2013)... Sunnyvale, California (PRWEB) May 21, 2013 ... invites individuals who are grieving to remember and honor ... an Evening of Remembrance Memorial Service, Sunday, June 2, ... at Skyline Boulevard, San Mateo, CA 94402. , ... non-denominational, and includes a short program with music, readings ...

(Date:5/21/2013)... Calif. (PRWEB) May 21, 2013 Not ... a dual diagnosis of Borderline Personality Disorder (BPD) and ... is proving to be successful for the treatment of ... 1, Alina Gorgorian, Ph.D., clinical director of Clearview ... in Los Angeles, will provide attendees of the West ...

(Date:5/21/2013)... more likely than their normal-weight counterparts to repeatedly ... continuity of care and leads to more emergency ... The practice of "doctor shopping" among overweight patients ... the health care system, whether that be off-putting ... by providers, or improperly sized medical equipment and ...

(Date:5/21/2013)... N.C. An attack on glioblastoma brain tumor cells ... in an early study to establish the proper dose ... treatment, developed at Duke and tested in an ongoing ... cells have an abundance of receptors that work like ... the cells. , The investigational therapy, known as ...

Breaking Medicine News(10 mins):Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2 Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3 Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2 Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2 Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3 Health News:'Doctor shopping' by obese patients negatively affects health 2 Health News:'Doctor shopping' by obese patients negatively affects health 3 Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2

[0] Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer [0] Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California [0] Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD [0] 'Doctor shopping' by obese patients negatively affects health [0] Poliovirus vaccine trial shows early promise for recurrent glioblastoma

... makers debate what levels of ozone in the air are ... that the inhaled pollutant impairs the bodys first line of ... as bacteria. , While it has long been known ... pollution, is associated with increased cardiovascular and pulmonary hospitalizations and ...

... Programs in ... Need, BUDAPEST, Hungary, Sept. 29 With more ... each year, it has never,been more critical to increase ... the U.S.-Middle East Partnership for,Breast Cancer Awareness and Research, ...

... finds 123 deaths linked to the products since 1969 ... experts on Friday urged the federal Food and Drug ... and cold medicines for young children. , The recommendation, ... in children under 2, and antihistamines in those younger ...

... MCLEAN, Va., Sept. 28 Sunrise Senior Living,Inc. ... on the status of the independent,investigation being conducted ... Directors, provided an update on management,s Sarbanes-Oxley,Section 404 ... on legal,proceedings. Special Independent Committee Investigation ...

... a,statement by ADA President Kathleen Roth, DDS, on ... Bill: "The American Dental Association applauds the ... in legislation reauthorizing,the State Children,s Health Insurance Program. ... care that they need to enjoy good,oral health. ...

... Medical today announced a,partnership with leading breast care ... including breast care physicians from,Connecticut to California, will ... and availability of an innovative, non-surgical,treatment option for ... will host a gathering of these new Centers ...

Ozone shuts down early immune response in lungs and body Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries FDA Advisers Urge Ban on Cold Medicines for Young Children Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Management's Internal Control Review Efforts and on Legal Proceedings Statement by ADA President Kathleen Roth, DDS, on the Inclusion of Stable Dental Benefit in SCHIP Reauthorization Bill Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas

(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue: ... for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... to offer synopsis of the current and ...

(Date:5/21/2013)... , May 21, 2013 Healthcare organizations expanding into ... Russia , India ... there are no shortcuts. This is proving particularly challenging, ... States. Companies must change the dialogue around BRIC, as ... local needs, and building regional partnerships to build a ...

(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue: ... for Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario ... Summary ...

[0] Global Markets and Technologies for Optical Coherence Tomography (OCT)[0] Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets [0] Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market

... Aug. 24 With flu season fast approaching, PTCB ... role in immunization efforts at retail pharmacies across the ... 7.4 million patients against H1N1 and seasonal influenza with ... the 2010–2011 influenza season, Walgreens healthcare providers in pharmacies ...

... Inc. (Nasdaq: VRUS ) announced today that dosing has ... polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The ... with pegylated interferon alfa 2a and ribavirin, the current standard of ... been treated previously. "We look for the Phase ...

Cached Medicine Technology:PTCB Certified Pharmacy Technicians Play a Critical Role in Immunization Campaigns 2 Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3 2 Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3 3 Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3 4

PTCB Certified Pharmacy Technicians Play a Critical Role in Immunization Campaigns Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

Medicine Products:

Allergen, Food, Chocolate IgG Allergen, Food, Clam Allergen, Food, Cherry Allergen, Food, Chili Pepper